"MIRACLE" FAT-MELTING DRUG OZEMPIC HAS been linked in a study to a series of rare but potentially fatal psychiatric episodes, scientists have warned.
The injectable prescription drug was developed to manage blood sugar levels in patients with Type 2 diabetes, but it has gained popularity and gone viral on social media due to one sought-after side effect: weight loss.
Ozempic is based on a naturally occurring human hormone called glucagon-like peptide 1, which plays an important role in regulating appetite and blood sugar levels. Its active ingredient is a molecule called semaglutide, which mimics the structure of this GLP-1 hormone and activates its receptors.
In doing so, semaglutide induces feelings of fullness while delaying the emptying of our stomach, making us less hungry and therefore less likely to overeat.
Semaglutide is also used in Ozempic's sister drug, Wegovy, which has been approved by the FDA for chronic weight management. Between the start of 2020 and the end of 2022, prescriptions of GLP-1 mimic medications like semaglutide increased by 300 percent across the U.S., according to health care analytics firm Trilliant Health.
The drug has since been endorsed by celebrities and influencers, with #ozempic reaching over 1.4 billion views on TikTok. However, when used as a weight-loss drug, semaglutide has been shown to have some uncomfortable side effects.
Most studies into these have focused on gut problems, but a new study, published in the International Journal of Clinical Pharmacy, has highlighted a concerning association between semaglutide and adverse psychiatric events, including depression, anxiety and suicidal thoughts. Pharmaceutical manufacturer Novo Nordisk, which produces Ozempic and Wegovy, cited the FDA saying that no evidence was found regarding suicidal thoughts or actions caused by these medicines.
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Zachary Quinto
ZACHARY QUINTO HAS PLAYED DOCTORS BEFORE, BUT HE'S \"NEVER PLAYED a doctor like\" the one he plays on NBC's Brilliant Minds (September 23).
Adam Brody
NETFLIX KNOWS EXACTLY WHAT MILLENNIALS want, and it's to see Adam Brody and Kristen Bell fall in love.
Partners in Crime
Actor Joseph Gordon-Levitt shares his delight at teaming up with Shailene Woodley again in new Amazon Prime movie Killer Heat
HOW TO FIND A WORKPLACE THAT LOVES YOU BACK
Insights from America's Top Most Loved Workplaces
MOST LOVED WORKPLACES 2024
AT A TIME WHEN WORKERS ACROSS THE UNITED STATES CONTINUE TO redefine what they expect from their jobs, the companies on Newsweek's annual list of the Most Loved Workplaces in America are setting the standard for what a fulfilling workplace looks like.
Q&A LEE YARON
With 10/7, the professional became profoundly personal.
SDEROT INTERSECTION
How Jewish and Arab strangers united to rescue two little girls amidst Hamas' October 7 attack
No End in Sight
AS TENSIONS CONTINUE TO FLARE AT ISRAEL'S BORDERS, NEWSWEEK DISCOVERS HOW LIFE HAS CHANGED IN THE REGION A YEAR ON FROM THE OCTOBER 7 HAMAS ATTACKS
Thai Scammers Set Sights on US
Newsweek looks inside the Southeast Asian country's $2 billion cybercrime industry and how American citizens are now falling prey to sophisticated schemes run overseas
PARTING SHOT: Sarah Paulson
\"CAN YOU IMAGINE IF THE AIR WAS JUST FILLED WITH DUST PARTICLES and you literally could not breathe?\" That's what Sarah Paulson is tackling in her new film Hold Your Breath (October 3).
